Add to ORKGPrediction of signaling cross-talks contributing to acquired drug resistance in breast cancer cells by Bayesian statistical modelin
Abstract Background Mechanistic models of within-cell signal transduction networks can explain how t...
This paper concerns a study indicating that the expression levels of genes in signaling pathways can...
Targeted therapies have shown striking success in the treatment of cancer over the last years. Howev...
Small molecule inhibitors, such as lapatinib, are effective against breast cancer in clinical trials...
<div><p>Small molecule inhibitors, such as lapatinib, are effective against breast cancer in clinica...
Cancer patients often respond very differently to any given drug. Some patients respond very well, w...
One goal of precision medicine is to tailor effective treatments to patients' specific molecular mar...
Although genetic and epigenetic abnormalities in breast cancer have been extensively studied, it rem...
Increasing knowledge about signal transduction pathways as drivers of cancer growth has elicited the...
Increasing knowledge about signal transduction pathways as drivers of cancer growth has elicited the...
One goal of precision medicine is to tailor effective treatments to patients' specific molecular mar...
Predicting the best treatment strategy from genomic information is a core goal of precision medicine...
Resistance to targeted anti-cancer drugs is a complex phenomenon and a major challenge in cancer tre...
<p>This model summarizes our findings regarding signaling pathways activated in breast cancer cells ...
Epidermal growth factor receptor (EGFR) inhibitors have benefitted cancer patients worldwide, but re...
Abstract Background Mechanistic models of within-cell signal transduction networks can explain how t...
This paper concerns a study indicating that the expression levels of genes in signaling pathways can...
Targeted therapies have shown striking success in the treatment of cancer over the last years. Howev...
Small molecule inhibitors, such as lapatinib, are effective against breast cancer in clinical trials...
<div><p>Small molecule inhibitors, such as lapatinib, are effective against breast cancer in clinica...
Cancer patients often respond very differently to any given drug. Some patients respond very well, w...
One goal of precision medicine is to tailor effective treatments to patients' specific molecular mar...
Although genetic and epigenetic abnormalities in breast cancer have been extensively studied, it rem...
Increasing knowledge about signal transduction pathways as drivers of cancer growth has elicited the...
Increasing knowledge about signal transduction pathways as drivers of cancer growth has elicited the...
One goal of precision medicine is to tailor effective treatments to patients' specific molecular mar...
Predicting the best treatment strategy from genomic information is a core goal of precision medicine...
Resistance to targeted anti-cancer drugs is a complex phenomenon and a major challenge in cancer tre...
<p>This model summarizes our findings regarding signaling pathways activated in breast cancer cells ...
Epidermal growth factor receptor (EGFR) inhibitors have benefitted cancer patients worldwide, but re...
Abstract Background Mechanistic models of within-cell signal transduction networks can explain how t...
This paper concerns a study indicating that the expression levels of genes in signaling pathways can...
Targeted therapies have shown striking success in the treatment of cancer over the last years. Howev...